Cite
Impact of High-Risk Cytogenetics and Achievement of Molecular Remission on Long-Term Freedom from Disease after Autologous–Allogeneic Tandem Transplantation in Patients with Multiple Myeloma
MLA
Kröger, Nicolaus, et al. “Impact of High-Risk Cytogenetics and Achievement of Molecular Remission on Long-Term Freedom from Disease after Autologous–Allogeneic Tandem Transplantation in Patients with Multiple Myeloma.” Biology of Blood & Marrow Transplantation, vol. 19, no. 3, Mar. 2013, pp. 398–404. EBSCOhost, https://doi.org/10.1016/j.bbmt.2012.10.008.
APA
Kröger, N., Badbaran, A., Zabelina, T., Ayuk, F., Wolschke, C., Alchalby, H., Klyuchnikov, E., Atanackovic, D., Schilling, G., Hansen, T., Schwarz, S., Heinzelmann, M., Zeschke, S., Bacher, U., Stübig, T., Fehse, B., & Zander, A. R. (2013). Impact of High-Risk Cytogenetics and Achievement of Molecular Remission on Long-Term Freedom from Disease after Autologous–Allogeneic Tandem Transplantation in Patients with Multiple Myeloma. Biology of Blood & Marrow Transplantation, 19(3), 398–404. https://doi.org/10.1016/j.bbmt.2012.10.008
Chicago
Kröger, Nicolaus, Anita Badbaran, Tatjana Zabelina, Francis Ayuk, Christine Wolschke, Haefaa Alchalby, Evgeny Klyuchnikov, et al. 2013. “Impact of High-Risk Cytogenetics and Achievement of Molecular Remission on Long-Term Freedom from Disease after Autologous–Allogeneic Tandem Transplantation in Patients with Multiple Myeloma.” Biology of Blood & Marrow Transplantation 19 (3): 398–404. doi:10.1016/j.bbmt.2012.10.008.